A central role for inflammation in the pathogenesis of diabetic retinopathy

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Antonia M JoussenAnthony P Adamis

Abstract

Diabetic retinopathy is a leading cause of adult vision loss and blindness. Much of the retinal damage that characterizes the disease results from retinal vascular leakage and nonperfusion. Diabetic retinal vascular leakage, capillary nonperfusion, and endothelial cell damage are temporary and spatially associated with retinal leukocyte stasis in early experimental diabetes. Retinal leukostasis increases within days of developing diabetes and correlates with the increased expression of retinal intercellular adhesion molecule-1 (ICAM-1) and CD18. Mice deficient in the genes encoding for the leukocyte adhesion molecules CD18 and ICAM-1 were studied in two models of diabetic retinopathy with respect to the long-term development of retinal vascular lesions. CD18-/- and ICAM-1-/- mice demonstrate significantly fewer adherent leukocytes in the retinal vasculature at 11 and 15 months after induction of diabetes with STZ. This condition is associated with fewer damaged endothelial cells and lesser vascular leakage. Galactosemia of up to 24 months causes pericyte and endothelial cell loss and formation of acellular capillaries. These changes are significantly reduced in CD18- and ICAM-1-deficient mice. Basement membrane thickening of th...Continue Reading

References

Jun 29, 1979·Virchows Archiv. A, Pathological Anatomy and Histology·L S CutlerS B Russotto
Mar 1, 1970·American Journal of Ophthalmology·E M Kohner, P Henkind
May 1, 1995·Experimental Eye Research·T S Kern, R L Engerman
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J E SlighA L Beaudet
Jan 1, 1995·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·L E Caspers-VeluP F Kador
Jun 15, 1996·The Journal of Clinical Investigation·M MizutaniM Lorenzi
Aug 1, 1996·Archives of Ophthalmology·T S Kern, R L Engerman
Sep 15, 1999·Proceedings of the National Academy of Sciences of the United States of America·K MiyamotoA P Adamis
Jan 6, 2001·The American Journal of Pathology·A M JoussenA P Adamis
May 10, 2002·The American Journal of Pathology·Antonia M JoussenAnthony P Adamis
Oct 22, 2002·American Journal of Physiology. Endocrinology and Metabolism·S T KnudsenL M Rasmussen
Dec 12, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Antonia M JoussenLloyd Paul Aiello
Sep 1, 1961·Archives of Ophthalmology·D G COGANT KUWABARA
Oct 9, 2003·Ocular Immunology and Inflammation·Koray KaradayiOğuz Gülecek

❮ Previous
Next ❯

Citations

May 14, 2011·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Nupura KrishnadevCatherine Meyerle
Feb 19, 2011·Molecules and Cells·Young Hee KimGyeong Jae Cho
Apr 3, 2007·Japanese Journal of Ophthalmology·Miwako KawashimaYukihiro Sato
Apr 11, 2009·Apoptosis : an International Journal on Programmed Cell Death·Aidan RyanFionnuala B Hickey
Jan 1, 2008·Journal of Molecular Histology·Taoufik KhalfaouiAmel Ouertani-Meddeb
Jul 26, 2008·Reviews in Endocrine & Metabolic Disorders·Sally A Madsen-Bouterse, Renu A Kowluru
Dec 1, 2005·Current Diabetes Reports·Carmen Mora, Juan F Navarro
Jun 6, 2007·Current Diabetes Reports·Michael D Williams, Jerry L Nadler
May 15, 2012·Current Diabetes Reports·Michael W Stewart
Jun 1, 2011·Journal of Ocular Biology, Diseases, and Informatics·Gregory I LiouAhmed S Ibrahim
Jun 1, 2011·Journal of Ocular Biology, Diseases, and Informatics·Alan W Stitt, Timothy M Curtis
Jun 1, 2011·Journal of Ocular Biology, Diseases, and Informatics·Prathiba Jayaguru, Susanne Mohr
Jun 1, 2011·Journal of Ocular Biology, Diseases, and Informatics·Steven F Abcouwer
Nov 5, 2013·Trends in Endocrinology and Metabolism : TEM·Rafael SimóUNKNOWN European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR)
Jul 28, 2004·The American Journal of Pathology·Vassiliki PoulakiAnthony P Adamis
Sep 1, 2007·Bioconjugate Chemistry·Ashwath JayagopalFrederick R Haselton
Sep 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yunpeng DuTimothy S Kern
Sep 29, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Juan F Navarro, Carmen Mora
Feb 2, 2011·Clinical and Experimental Pharmacology & Physiology·Mutallip ObulkasimJun Ren
Jul 21, 2007·Experimental Diabetes Research·Renu A Kowluru, Pooi-See Chan
Apr 24, 2012·Journal of Ophthalmology·Dinah Zur, Anat Loewenstein
Feb 1, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Abdulrahman L Al-Malki
Apr 2, 2008·Investigative Ophthalmology & Visual Science·Mohamed Al-ShabraweyRuth B Caldwell
Jul 13, 2013·Investigative Ophthalmology & Visual Science·Monique S RoyRobert Donnelly
Apr 18, 2007·Nutrition & Metabolism·Renu A Kowluru, Mamta Kanwar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here